Cargando…
Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors
The aim of this study was to investigate the clinical characteristics and efficacy of chronic myeloid leukemia (CML) onset with extreme thrombocytosis. A total of 121 newly diagnosed and untreated CML patients in chronic phase with complete clinical information from the First Hospital of Jilin Unive...
Autores principales: | Liu, Zhihe, Fan, Hongqiong, Li, Yuying, Liu, Chunshui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522826/ https://www.ncbi.nlm.nih.gov/pubmed/28761360 http://dx.doi.org/10.2147/OTT.S142587 |
Ejemplares similares
-
Chronic myeloid leukemia with extreme thrombocytosis
por: Kim, So Young, et al.
Publicado: (2012) -
Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
por: Castillo, Dan Ran, et al.
Publicado: (2022) -
The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era
por: Kockerols, Camille C.B., et al.
Publicado: (2022) -
Chronic Myeloid Leukemia: A Case of Extreme Thrombocytosis Causing Syncope and Myocardial Infarction
por: Ebrahem, Rawaa, et al.
Publicado: (2016) -
Chronic myeloid leukemia therapy in the era of tyrosine kinase inhibitors. The first molecular targeted treatment
por: Bumbea, H, et al.
Publicado: (2010)